Third Rock Ventures V, L.P. disclosed sell in Rapport Therapeutics, Inc. Common Stock
Third Rock Ventures V, L.P. sell $743.8K of disclosed value in Rapport Therapeutics, Inc. Common Stock.
Signal
Insider Trade
Action
Sell
Capital
$743.8K disclosed value
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from canonical action facts, not request-time scraping.